b9
13
8b Immunobiology Program
19 19 19 31 19 65 19 31 19 19 19 19 19 45Program Leaders: Warren Pear, MD, PhD and E. John Wherry, PhD
bcThe Immunobiology Program serves as a rich resource for the Abramson Cancer Center in advancing an understanding of immunobiology and immunotherapy of cancer. The Program aims to:
6-
ac
- Understand the fundamental aspects of immune biology, including leukocyte activation, differentiation, inactivation, and transformation as these relate to cancer a7
- Forge a comprehensive understanding of tumor immune surveillance using state-of-the art in vitro, animal model, and human experimental systems 8a
- Guide translation of novel clinical strategies for immunotherapy of cancer by leading or collaborating on human clinical trials 7
The Program Leaders are Warren Pear, MD, PhD, an expert in the molecular biology of leukocyte development and malignant transformation and E. John Wherry, PhD, a leader in tumor immunology, immune exhaustion and immunotherapy. Drs. Pear and Wherry are experienced, NCI-funded investigators who are highly collaborative and whose research interests span the realm of basic and translational science. Members include international leaders in basic immunology, tumor immunobiology and translational immunotherapy who have driven landmark breakthroughs such as molecularly defining T cell exhaustion, dissecting the biologic response to checkpoint inhibition, and developing CAR T cells that revolutionized cellular therapy for cancer. Immunobiology Program members collaborate extensively with other Programs for clinical translation and biomarker discovery.
2bImmunobiology Program Membership
20-
50
- David Allman, PhD 6b
- Hajera Amatullah, PhD 6e
- Sokratis Apostolidis, MD 78
- Michael Atchison, PhD 78
- Matthew Atherton, PhD 51
- Will Bailis, PhD 56
- Gregory Beatty, MD, PhD 55
- Janis Burkhardt, PhD 5b
- Frederic Bushman, PhD 66
- Ken Cadwell, PhD 55
- Beatriz Carreno, PhD 5a
- Ronald DeMatteo, MD, FACS 75
- Laurence Eisenlohr, VMD, PhD 55
- Joseph Fraietta, PhD 5c
- Mohammad Haj Dezfulian, PhD 56
- Malay Haldar, MD, PhD 72
- Wayne Hancock, MD, PhD, FRCPA 5b
- Jorge Henao-Mejia, MD, PhD 54
- Alexander Huang, MD 7b
- Christopher Hunter, PhD 61
- Ning Jenny Jiang, PhD 54
- Chengcheng Jin, PhD 4b
- Carl June, MD 4c
- Mark Kahn, MD 59
- Taku Kambayashi, MD, PhD 66
- Dokyoon Kim, PhD 4f
- John Lambris, PhD 4f
- Bruce Levine, PhD 4b
- Bo Li, PhD 59
- Eline Luning Prak, MD, PhD 56
- Nilam Mangalmurti, MD 74
- Nicola Mason, PhD, VMD 5c
- Susan McClory, MD, PhD 58
- Michael Milone, MD, PhD 58
- Jonathan Miner, MD, PhD 51
- Jonni Moore, PhD 78
- Roderick O'Connor, MS, PhD 52
- Paula Oliver, PhD 71
- Hamideh Parhiz, PharmD, PhD 52
- Warren Pear, MD, PhD 69
- Daniel Powell, PhD 65
- James Riley, PhD 6a
- Nikolaos Sgourakis, PhD 59
- Kathleen Sullivan, MD, PhD 6f
- Cornelius Taabazuing, PhD 53
- Golnaz Vahedi, PhD 5b
- Robert Vonderheide, MD, DPhil 50
- Evan Weber, PhD 55
- Drew Weissman, MD, PhD 54
- E. John Wherry, PhD 24